Financhill
Buy
59

DYN Quote, Financials, Valuation and Earnings

Last price:
$20.36
Seasonality move :
-5.63%
Day range:
$20.23 - $20.74
52-week range:
$6.36 - $26.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.20x
Volume:
971K
Avg. volume:
3M
1-year change:
-15.1%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$3.66

Earnings Data

Next earnings date for DYN
Feb 26
2026
Most recent earnings per share
-$0.76
Beat by $0.08
(Nov 5/2025)
Consensus Estimate
-$0.85
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DYN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 -- -- -- -$0.76 --
11/05/2025 Q3 -- -- -$0.76 -$0.85 $0.08
07/28/2025 Q2 -- -- -$0.97 -$0.93 -$0.04
05/01/2025 Q1 -- -- -$1.05 -$0.84 -$0.21
02/27/2025 Q4 -- -- -$0.88 -$0.91 $0.04
11/12/2024 Q3 -- -- -$0.96 -$0.71 -$0.25
08/12/2024 Q2 -- -- -$0.70 -$0.72 $0.02
05/02/2024 Q1 -- -- -$0.81 -$0.81 $0.00
03/05/2024 Q4 -- -- -$1.09 -$0.93 -$0.16
10/30/2023 Q3 -- -- -$0.99 -$0.76 -$0.22
08/03/2023 Q2 -- -- -$1.08 -- --
05/11/2023 Q1 -- -- -$0.78 -- --
03/02/2023 Q4 -- -- -$0.74 -- --
11/03/2022 Q3 -- -- -$0.80 -- --
08/04/2022 Q2 -- -- -$1.01 -- --
05/02/2022 Q1 -- -- -$0.69 -- --
03/10/2022 Q4 -- -- -$1.00 -- --
11/04/2021 Q3 -- -- -$0.83 -- --
08/05/2021 Q2 -- -- -$0.58 -- --
05/06/2021 Q1 -- -- -$0.50 -- --
03/04/2021 Q4 -- -- -$0.64 -- --
11/05/2020 Q3 -- -- -$2.01 -- --
06/30/2020 Q2 -- -- -$0.22 -- --
03/31/2020 Q1 -- -- -$0.62 -- --
12/31/2019 Q4 -- -- -$0.42 -- --
09/30/2019 Q3 -- -- -$0.13 -- --
05/02/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
11/01/2016 Q3 -- -- $0.01 $0.07 -$0.06
08/03/2016 Q2 -- -- -- -- --
05/03/2016 Q1 -- -- -- -- --
02/24/2016 Q4 -- -- -- -- --

Dyne Therapeutics, Inc. Earnings Questions

  • How Much did Dyne Therapeutics, Inc. Generate in Revenue Last Quarter?

    Dyne Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Dyne Therapeutics, Inc. Beat Earnings Last Quarter?

    Dyne Therapeutics, Inc. announced earnings per share of -$0.76 which represents a beat of analyst forecast a -$0.85 per share.

  • Is Dyne Therapeutics, Inc. Profitable?

    Dyne Therapeutics, Inc. reported -$500K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Dyne Therapeutics, Inc. EPS Next Year?

    Dyne Therapeutics, Inc.'s earnings are forecast to decrease from -$3.37 per share to -$3.45 per share next year representing a decrease of -5.32%.

  • When is Dyne Therapeutics, Inc.'s Earnings Date?

    Dyne Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock